Posted by Michael Wonder on 09 Jul 2020
U.S. FDA approves Qwo (collagenase clostridium histolyticum-aaes), the first injectable treatment for cellulite
6 July 2020 - Endo International today announced that it received U.S. FDA approval of Qwo (collagenase clostridium histolyticum-aaes) for the treatment of moderate to severe cellulite in the buttocks of adult women.
Qwo is the first FDA approved injectable treatment for cellulite.
Qwo is expected to be available throughout the United States at aesthetic healthcare practitioner's offices starting in Spring 2021.
